Phase II study of primary chemotherapy with paclitaxel, gemcitabine, and trastuzumab in patients with HER [human epidermal growth factor receptor] 2 positive operable breast cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Paclitaxel; Trastuzumab
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2012 Biomarkers information updated
- 03 Jan 2012 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 03 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.